Skip to main navigation Skip to main content Skip to page footer
The "ARISTOIL" program distinguished in Europe

THE "ARISTOIL" PROGRAM DISTINGUISHED IN EUROPE

On 31/5/2019 it was announced that the European program INTERREG MED "ARISTOIL", for which NKUA has the scientific coordination, was selected as the best program in its category for 2019 among dozens of interregional European programs (http://www.interact-eu.net/#o = node/2613) and will compete in October in Brussels together with 7 other top…

Important contribution of NKUA research team at CMS experiment at CERN.

IMPORTANT CONTRIBUTION OF NKUA RESEARCH TEAM AT CMS EXPERIMENT AT CERN.

The research team of Assoc. Prof. Niki  Saoulidou of the Physics Department of the National and Kapodistrian University of Athens (NKUA), Greece,  played a leading  role, collaborating with research teams from around the globe,  in  a powerful new physics search of the CMS experiment at the CERN's Large Hadron Collider. Prof. Saoulidou worked…

"NEW LEADERS " AWARD OF THE FÉDÉRATION INTERNATIONALE D´ÉDUCATION PHYSIQUE (FIEP)

"NEW LEADERS " AWARD OF THE FÉDÉRATION INTERNATIONALE D´ÉDUCATION PHYSIQUE (FIEP)

The International Federation of Physical Education (FIEP) http://fiepeurope.eu/  just completed its 30th FIEP World Congress, and the 14th FIEP European Congress (27-29 June) in Barcelona, Spain under the theme:  "SPORT AND PHYSICAL EDUCATION AND SCENIC ARTS AS TOOLS OF SOCIAL TRANSFORMATION." As regards the young researchers awards for the…

Novel therapy for idiopathic pulmonary fibrosis (IPF)

NOVEL THERAPY FOR IDIOPATHIC PULMONARY FIBROSIS (IPF)

Patients with idiopathic pulmonary fibrosis treated with a recombinant human pentraxin 2 protein exhibited sustained reductions in decline of FVC and 6-minute walking distance at 76 weeks, according to data presented at the American Thoracic Society International Conference and simultaneously published in The Lancet Respiratory Medicine.

In…